Amoxicillin/Clavulanate related extreme thrombocytosis during the treatment of pneumonia has never been reported. We present a 54-year-old patient who was admitted due to pneumonia, and was treated with amoxicillin/clavulanate IV and 3-day course of 500 mg azithromycin. Despite clinical and radiological evidence showing that pneumonia improved, thrombocytes increased rapidly. After stopping the antibiotic, the thrombocytes returned gradually to normal. Considering the clinical course, we propose that this extreme thrombocytosis was caused by the administration of amoxicillin/clavulanate. We describe this rare and unique patient and review the literature.
Finsterer J, Kotzailias N. Thrombocytosis under ciprofloxacin and tazobactam/piperacillin. Platelets 2003;14:329–331.PubMedCrossRefGoogle Scholar
Moody SB, Pawlicki KS. Thrombocytosis and hyperkalemia associated with the use of ticarcillin/clavulanic acid. Drug Intell Clin Pharm 1987;21:292–293.PubMedGoogle Scholar
Kristjansson K, Cox F, Taylor L. Ticarcillin/clavulanic acid combination. Treatment of bacterial infections in hospitalized children. Clin Pediatr (Phila) 1989;28:521–524.Google Scholar
Elliott MA, Tefferi A. Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia. Br J Haematol 2005;128:275–290.PubMedCrossRefGoogle Scholar
Buss DH, Stuart JJ, Lipscomb GE. The incidence of thrombotic and hemorrhagic disorders in association with extreme thrombocytosis: an analysis of 129 cases. Am J Hematol 1985;20:365–372.PubMedGoogle Scholar
Buss DH, Cashell AW, O’Connor ML, Richards F, Case LD. Occurrence, etiology, and clinical significance of extreme thrombocytosis: a study of 280 cases. Am J Med 1994;96:247–253.PubMedCrossRefGoogle Scholar
Saathoff AD, Elkins SL, Chapman SW, McAllister SF, Cleary JD. Thrombocytosis during antifungal therapy of candidemia. Ann Pharmacother 2005;39:1238–1243.PubMedCrossRefGoogle Scholar